Outputs (2)

British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine (2023)
Journal Article
Russell, M. D., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K., Khamashta, M., Moore, L., Panchal, S., Piper, M., Reid, C., Saxby, K., Schreiber, K., Senvar, N., Tosounidou, S., van de Venne, M., Warburton, L., …Giles, I. (2024). British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine. Rheumatology, 63(2), e37-e38. https://doi.org/10.1093/rheumatology/kead384

Management of systemic sclerosis: British Society for Rheumatology guideline scope (2023)
Journal Article
Denton, C. P., De Lorenzis, E., Roblin, E., Goldman, N., Alcacer-Pitarch, B., Blamont, E., Buch, M., Carulli, M., Cotton, C., del Galdo, F., Derrett-Smith, E., Douglas, K., Farrington, S., Fligelstone, K., Gompels, L., Griffiths, B., Herrick, A., Hughes, M., Pain, C., Pantano, G., …Ong, V. (2023). Management of systemic sclerosis: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 7(1), https://doi.org/10.1093/rap/rkad022

AbstractThis guideline will provide a practical roadmap for management of SSc that builds upon the previous treatment guideline to incorporate advances in evidence-based treatment and increased knowledge about assessment, classification and managemen... Read More about Management of systemic sclerosis: British Society for Rheumatology guideline scope.